We are live on
!
Find out more
RVNC
Revance Therapeutics, Inc.
RVNC
RVNC
Delisted
RVNC was delisted on the 5th of February, 2025.
78 hedge funds and large institutions have $546M invested in Revance Therapeutics, Inc. in 2017 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 23 increasing their positions, 28 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
97% more call options, than puts
Call options by funds: $687K | Put options by funds: $349K
22% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 9
1% more capital invested
Capital invested by funds: $540M → $546M (+$6.08M)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
4% less funds holding
Funds holding: 81 → 78 (-3)
18% less repeat investments, than reductions
Existing positions increased: 23 | Existing positions reduced: 28
Holders
78
Holders Change
-3
Holders Change %
-3.7%
% of All Funds
1.94%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
11
Increased
23
Reduced
28
Closed
9
Calls
$687K
Puts
$349K
Net Calls
+$338K
Net Calls Change
-$26K
Top Buyers
| 1 |
BlackRock
New York
|
+$42M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$4.46M |
| 3 |
Goldman Sachs
New York
|
+$2.9M |
| 4 |
State Street
Boston,
Massachusetts
|
+$2.56M |
| 5 |
PC
PointState Capital
New York
|
+$2.08M |
